インターベンショナルニューロラジオロジー - 市場考察、競合情勢、市場予測（2032年）

世界のインターベンショナルニューロラジオロジーの市場規模は、2024年に311億9,887万米ドルであり、2032年までに520億8,152万米ドルに達すると予測され、2025年～2032年の予測期間にCAGRで6.66%の成長が見込まれます。インターベンショナルニューロラジオロジーの需要は、主に神経疾患、特に脳動脈瘤、虚血性脳卒中、動静脈奇形（AVM）の罹患率の上昇よって促進されています。これらの疾患の有病率の増加は、患者転帰を改善し回復時間を短縮する低侵襲診断・治療手技の必要性を高めています。

さらに、技術の進歩が予測期間（2025年～2032年）における市場成長の推進に極めて重要な役割を果たしています。次世代フローダイバーター、柔軟性の高いマイクロカテーテル、強化されたイメージング技術、ロボット支援インターベンションなどの開発により、インターベンショナルニューロラジオロジー手技の精度、安全性、有効性が大幅に向上しています。これらの進歩により、以前は手術不可能とされていた、あるいは手術リスクが高いとされていた複雑な神経疾患の治療が可能になっています。

さらに、画像診断におけるAIと機械学習アルゴリズムの統合は、早期発見と治療計画を強化し、インターベンショナルニューロラジオロジーソリューションの採用を促進しています。低侵襲手技への選好の高まりは、患者の意識の高まりや医療インフラの改善もあり、さまざまな地域での市場拡大をさらに加速させています。

インターベンショナルニューロラジオロジーの市場力学

インターベンショナルニューロラジオロジー市場は、神経疾患の有病率の上昇、脳卒中の罹患率の増加、治療機器の継続的な技術の進歩により予測期間に大きく成長する見込みです。

Brain Aneurysm Foundation（2023）によると、米国では約670万人に未破裂の脳動脈瘤があり、年間約3万件の動脈瘤破裂が報告されています。脳動脈瘤の破裂はくも膜下出血のような生命を脅かす状態につながる可能性があり、血管内コイル塞栓術やフローダイバーターの使用のような緊急のインターベンション手技が必要となります。脳動脈瘤の有病率の増加により、脳動脈瘤に対する認識が高まり、診断能力が向上し、それに伴い先進のインターベンショナルニューロラジオロジー（INR）デバイスに対する需要が増加しています。早期発見・治療は死亡率を大幅に低下させ、長期的な転帰を改善するため、市場の成長をさらに後押ししています。

脳卒中の流行もまた、市場需要を刺激する重大な要因です。Global Stroke Fact Sheet（2022）によると、2022年に世界で約1,222万件の脳卒中が発生し、そのうち760万件超が虚血性脳卒中で、脳卒中全体の62%を占めています。虚血性脳卒中は動脈の閉塞が原因で発生し、機械的血栓除去術やステント回収術などのインターベンショナルニューロラジオロジー技術は、血流を回復させ、長期障害のリスクを低減させるのに不可欠です。タイムリーな介入は患者の回復と生存率を著しく向上させるため、救急医療現場でのINR手技の採用が後押しされています。

インターベンショナルニューロラジオロジー分野における技術革新は、市場の拡大をさらに後押ししています。進歩には、柔軟性、耐久性、生体適合性を向上させた次世代ステントやフローダイバーターの開発が含まれ、これにより性能が向上し、ステント内血栓症やデバイスの移動などの合併症が減少しています。さらに、マイクロカテーテルやマイクロガイドワイヤーの技術革新により、脳の複雑な血管網を通過する精度と成功率が向上し、複雑な動脈瘤や動静脈奇形（AVM）のより安全で効果的な治療が可能になっています。ロボット支援インターベンションやリアルタイムイメージングの進歩といった最先端技術も、回復時間の短縮とリスクの低減を実現する低侵襲手技を可能にし、患者と医療提供者の双方にますます好まれるものとなっています。

このようなプラスの要因にもかかわらず、市場はインターベンションデバイスに関連する合併症（血管穿孔、デバイスの移動、血栓塞栓症など）や、デバイスの承認に対する厳しい規制情勢といった課題に直面しています。規制当局は安全性と有効性を確保するために広範な臨床データを要求するため、製品の上市が遅れ、開発コストが増大する可能性があります。

とはいえ、神経・脳血管疾患の世界的な負担の増大、早期介入の利点に対する意識の高まり、継続的な技術の進歩は課題を上回り、2025年～2032年の予測期間にインターベンショナルニューロラジオロジー市場の成長を促進する見込みです。

当レポートでは、世界のインターベンショナルニューロラジオロジー市場について調査分析し、市場規模と予測、過去3年の製品/技術開発、市場の主要企業、利用可能な機会などの情報を提供しています。

目次

第1章 インターベンショナルニューロラジオロジー市場レポートのイントロダクション

第2章 インターベンショナルニューロラジオロジー市場のエグゼクティブサマリー

• 市場の概要

第3章 競合情勢

第4章 規制分析

• 米国
• 欧州
• 日本
• 中国

第5章 インターベンショナルニューロラジオロジー市場の主な要因の分析

• インターベンショナルニューロラジオロジー市場の促進要因
• インターベンショナルニューロラジオロジー市場の抑制要因と課題
• インターベンショナルニューロラジオロジー市場の機会

第6章 インターベンショナルニューロラジオロジー市場のポーターのファイブフォース分析

第7章 インターベンショナルニューロラジオロジー市場の評価

• デバイス別
  • マイクロガイドワイヤー
  • マイクロカテーテル
  • フローダイバーターステント
  • 塞栓コイル
  • 神経血管塞栓デバイス
  • その他
• 疾患別
  • 脳動脈瘤
  • 頭蓋内腫瘍
  • 急性虚血性脳卒中
  • その他の疾患
• エンドユーザー別
  • 病院
  • 外来手術センター
• 地域
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第8章 インターベンショナルニューロラジオロジー市場の企業と製品のプロファイル

• Stryker
• Boston Scientific Corporation
• MicroVention Inc.
• Cook
• Mediterra
• Johnson & Johnson, Inc.
• Merit Medical Systems, Inc.
• Terumo Corporation
• Penumbra, Inc.
• MicroPort Scientific Corporation
• Balt Group
• AngioDynamics
• Acandis GmBH
• Phenox GmbH
• InspireMD Inc.

第9章 KOLの見解

第10章 プロジェクトのアプローチ

第11章 DelveInsightについて

第12章 免責事項、お問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: Interventional Neuroradiology Market in Global (2022-2032)
• Table 3: Interventional Neuroradiology Market in Global by Device (2022-2032)
• Table 4: Interventional Neuroradiology Market in Global by Disease (2022-2032)
• Table 5: Interventional Neuroradiology Market in Global by End-User (2022-2032)
• Table 6: Interventional Neuroradiology Market in Global by Geography (2022-2032)
• Table 7: Interventional Neuroradiology Market in North America (2022-2032)
• Table 8: Interventional Neuroradiology Market in the United States (2022-2032)
• Table 9: Interventional Neuroradiology Market in Canada (2022-2032)
• Table 10: Interventional Neuroradiology Market in Mexico (2022-2032)
• Table 11: Interventional Neuroradiology Market in Europe (2022-2032)
• Table 12: Interventional Neuroradiology Market in France (2022-2032)
• Table 13: Interventional Neuroradiology Market in Germany (2022-2032)
• Table 14: Interventional Neuroradiology Market in United Kingdom (2022-2032)
• Table 15: Interventional Neuroradiology Market in Italy (2022-2032)
• Table 16: Interventional Neuroradiology Market in Spain (2022-2032)
• Table 17: Interventional Neuroradiology Market in the Rest of Europe (2022-2032)
• Table 18: Interventional Neuroradiology Market in Asia-Pacific (2022-2032)
• Table 19: Interventional Neuroradiology Market in China (2022-2032)
• Table 20: Interventional Neuroradiology Market in Japan (2022-2032)
• Table 21: Interventional Neuroradiology Market in India (2022-2032)
• Table 22: Interventional Neuroradiology Market in Australia (2022-2032)
• Table 23: Interventional Neuroradiology Market in South Korea (2022-2032)
• Table 24: Interventional Neuroradiology Market in Rest of Asia-Pacific (2022-2032)
• Table 25: Interventional Neuroradiology Market in the Rest of the World (2022-2032)
• Table 26: Interventional Neuroradiology Market in the Middle East (2022-2032)
• Table 27: Interventional Neuroradiology Market in Africa (2022-2032)
• Table 28: Interventional Neuroradiology Market in South America (2022-2032)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: Interventional Neuroradiology Market in Global (2022-2032)
• Figure 3: Interventional Neuroradiology Market in Global by Device (2022-2032)
• Figure 4: Interventional Neuroradiology Market in Global by Disease (2022-2032)
• Figure 5: Interventional Neuroradiology Market in Global by End-User (2022-2032)
• Figure 6: Interventional Neuroradiology Market in Global by Geography (2022-2032)
• Figure 7: Interventional Neuroradiology Market in North America (2022-2032)
• Figure 8: Interventional Neuroradiology Market in the United States (2022-2032)
• Figure 9: Interventional Neuroradiology Market in Canada (2022-2032)
• Figure 10: Interventional Neuroradiology Market in Mexico (2022-2032)
• Figure 11: Interventional Neuroradiology Market in Europe (2022-2032)
• Figure 12: Interventional Neuroradiology Market in France (2022-2032)
• Figure 13: Interventional Neuroradiology Market in Germany (2022-2032)
• Figure 14: Interventional Neuroradiology Market in United Kingdom (2022-2032)
• Figure 15: Interventional Neuroradiology Market in Italy (2022-2032)
• Figure 16: Interventional Neuroradiology Market in Spain (2022-2032)
• Figure 17: Interventional Neuroradiology Market in the Rest of Europe (2022-2032)
• Figure 18: Interventional Neuroradiology Market in Asia-Pacific (2022-2032)
• Figure 19: Interventional Neuroradiology Market in China (2022-2032)
• Figure 20: Interventional Neuroradiology Market in Japan (2022-2032)
• Figure 21: Interventional Neuroradiology Market in India (2022-2032)
• Figure 22: Interventional Neuroradiology Market in Australia (2022-2032)
• Figure 23: Interventional Neuroradiology Market in South Korea (2022-2032)
• Figure 24: Interventional Neuroradiology Market in Rest of Asia-Pacific (2022-2032)
• Figure 25: Interventional Neuroradiology Market in the Rest of the World (2022-2032)
• Figure 26: Interventional Neuroradiology Market in the Middle East (2022-2032)
• Figure 27: Interventional Neuroradiology Market in Africa (2022-2032)
• Figure 28: Interventional Neuroradiology Market in South America (2022-2032)
• Figure 29: Market Drivers
• Figure 30: Market Barriers
• Figure 31: Marker Opportunities
• Figure 32: PORTER'S Five Force Analysis

Interventional Neuroradiology Market by Device (Micro guidewires, Microcatheters, Flow Diversion Stents, Embolization Coils, Neurovascular Embolization Devices, and Others), Disease (Cerebral Aneurysms, Intra-cranial Tumors, Acute Ischemic Strokes, and Other Diseases), End-Users (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 owing to the rising incidence of neurological disorders such as cerebral aneurysms and growing technical advancements in the domain of interventional neuroradiology

The interventional neuroradiology market was valued at USD 31,198.87 million in 2024, growing at a CAGR of 6.66% during the forecast period from 2025 to 2032 to reach USD 52,081.52 million by 2032. The demand for interventional neuroradiology is primarily driven by the rising incidence of neurological disorders, particularly cerebral aneurysms, ischemic strokes, and arteriovenous malformations (AVMs). The growing prevalence of these conditions has heightened the need for minimally invasive diagnostic and therapeutic procedures to improve patient outcomes and reduce recovery times.

Additionally, advancements in technology are playing a pivotal role in propelling market growth during the forecast period (2025 to 2032). Innovations such as the development of next-generation flow diversion devices, highly flexible microcatheters, enhanced imaging technologies, and robot-assisted interventions have significantly improved the precision, safety, and efficacy of interventional neuroradiology procedures. These advancements have enabled the treatment of complex neurological conditions that were previously considered inoperable or carried higher surgical risks.

Furthermore, the integration of artificial intelligence (AI) and machine learning algorithms in diagnostic imaging is enhancing early detection and treatment planning, thereby driving the adoption of interventional neuroradiology solutions. The increasing preference for minimally invasive procedures, combined with rising patient awareness and improved healthcare infrastructure, is further accelerating market expansion across various regions.

Interventional Neuroradiology Market Dynamics:

The interventional neuroradiology market is projected to experience significant growth during the forecast period, driven by the rising prevalence of neurological disorders, increasing incidence of strokes, and ongoing technological advancements in treatment devices.

According to the Brain Aneurysm Foundation (2023), approximately 6.7 million people in the United States have an unruptured brain aneurysm, with around 30,000 cases of aneurysm rupture reported annually. Brain aneurysm ruptures can lead to life-threatening conditions such as subarachnoid hemorrhage and require urgent interventional procedures like endovascular coiling or the use of flow diverters. The increasing prevalence of brain aneurysms has resulted in heightened awareness, improved diagnostic capabilities, and a corresponding rise in demand for advanced interventional neuroradiology (INR) devices. Early detection and treatment significantly reduce mortality and improve long-term outcomes, further propelling market growth.

Stroke prevalence is another critical factor fueling market demand. According to the Global Stroke Fact Sheet (2022), there were approximately 12.22 million incident stroke cases globally in 2022, with over 7.6 million ischemic strokes accounting for 62% of all strokes. Ischemic strokes occur due to blocked arteries, and interventional neuroradiology techniques such as mechanical thrombectomy and stent retrievers are essential in restoring blood flow and reducing the risk of long-term disability. Timely interventions significantly improve patient recovery and survival rates, which has boosted the adoption of INR procedures across emergency care settings.

Technological innovations in the interventional neuroradiology field further support market expansion. Advancements include the development of next-generation stents and flow diverters with improved flexibility, durability, and biocompatibility, which enhance performance and reduce complications such as in-stent thrombosis or device migration. Moreover, innovations in microcatheter and microguidewire technologies have improved precision and navigability through the brain's complex vascular network, allowing for safer and more effective treatment of complex aneurysms and arteriovenous malformations (AVMs). Cutting-edge technologies like robot-assisted interventions and real-time imaging advancements are also enabling minimally invasive procedures with shorter recovery times and reduced risks, which are becoming increasingly preferred by both patients and healthcare providers.

Despite these positive drivers, the market faces challenges such as complications associated with interventional devices (e.g., vessel perforation, device migration, or thromboembolic events) and the stringent regulatory landscape for device approval. Regulatory authorities require extensive clinical data to ensure safety and efficacy, which can delay product launches and increase development costs.

Nevertheless, the rising global burden of neurological and cerebrovascular diseases, increasing awareness of early intervention benefits, and continuous technological progress are expected to outweigh the challenges, thereby propelling the growth of the interventional neuroradiology market during the forecast period from 2025 to 2032.

Interventional Neuroradiology Market Segment Analysis:

Interventional Neuroradiology Market by Device (Micro guidewires, Microcatheters, Flow Diversion Stents, Embolization Coils, Neurovascular Embolization Devices, and Others), Disease (Cerebral Aneurysms, Intra-cranial Tumors, Acute Ischemic Strokes, and Other Diseases), End-Users (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the device segment of the interventional neuroradiology market, the flow diversion stents category is projected to amass a significant revenue share in 2024, driven by their versatile applications, clinical advantages, and increasing product approvals that are collectively fueling market demand during the forecast period.

Flow diversion stents have emerged as a preferred treatment option for managing complex intracranial aneurysms, particularly those that are large, wide-necked, or fusiform cases that are challenging to treat with traditional methods such as endovascular coiling. These stents work by redirecting blood flow away from the aneurysm sac, promoting endothelial growth along the stent, and ultimately sealing off the aneurysm over time. Flow diversion therapy is especially beneficial for aneurysms that have recurred after previous treatments, offering a reliable alternative with long-term durability and lower recurrence rates.

One of the key benefits of flow diversion stents is their minimally invasive nature. The procedure is typically performed using a catheter-based delivery system through the femoral or radial artery, reducing the risks associated with open craniotomy and shortening recovery times. Unlike traditional coiling, direct manipulation of the aneurysm sac is avoided, significantly reducing the risk of rupture during the procedure. Moreover, many flow diversion techniques do not require adjunctive devices like coils or balloons, simplifying the intervention process and minimizing device-related complications.

The market growth for flow diversion stents is further fueled by a surge in product approvals and technological advancements. For instance, in December 2023, MicroPort(R) NeuroTech(TM) received approval from the Brazilian National Health Surveillance Agency (ANVISA) for its Tubridge(R) Vascular Reconstruction Device. The Tubridge(R) is a dense-mesh stent applying flow diversion therapy principles, designed specifically to treat large or giant wide-necked intracranial aneurysms. Such innovations offer improved device flexibility, better wall apposition, and enhanced navigability through tortuous cerebral vessels, making them suitable for treating complex cases with greater precision and safety.

Additionally, the rising prevalence of intracranial aneurysms, increased awareness of early diagnosis, and growing demand for minimally invasive interventions are key contributors to the expanding market share of flow diversion stents. As more healthcare facilities adopt these advanced devices and as clinical guidelines increasingly support their use for various aneurysm types, the adoption rate is expected to rise globally.

Therefore, owing to the aforementioned factors including their clinical efficacy, safety profile, technological advancements, and regulatory approvals the flow diversion stents category is poised to register significant growth, thereby driving the overall expansion of the interventional neuroradiology market during the forecast period (2025 to 2032).

North America is expected to dominate the overall interventional neuroradiology market:

North America is anticipated to account for the largest share of the interventional neuroradiology market in 2024, driven by a large patient pool affected by ischemic strokes, transient ischemic attacks (TIA), and a growing geriatric population. Additional factors such as advanced healthcare infrastructure, technological innovations, and robust product development pipelines are further propelling market growth in the region.

According to the Centers for Disease Control and Prevention (CDC) 2023, approximately 795,000 people in the United States experience a stroke each year, with 87% being ischemic strokes caused by a blockage of blood flow to the brain. The high prevalence of ischemic strokes, coupled with the need for rapid intervention to improve patient outcomes, has increased the demand for interventional neuroradiology devices, including mechanical thrombectomy devices, stent retrievers, and aspiration catheters.

The aging population in North America further contributes to the rising incidence of strokes and TIAs. According to the US Census Bureau 2021 report, over 54 million adults aged 65 and older were living in the United States in 2021. This demographic is expected to rise to approximately 85.7 million by 2050, representing nearly 20% of the overall US population. The elderly population, particularly those above 50 years, are at a higher risk of ischemic strokes and TIA due to age-related vascular changes such as arterial narrowing, arteriosclerosis, and atherosclerosis. This underscores the growing need for minimally invasive treatments to manage these conditions effectively.

Additionally, the high adoption rate of innovative technologies and the presence of major market players in the region foster continuous product launches and regulatory approvals. For example, the United States Food and Drug Administration (FDA) has expedited the approval of various neurovascular devices to enhance stroke care. The region's robust research and development activities, favorable reimbursement policies, and widespread use of advanced imaging technologies further support early diagnosis and prompt intervention, contributing to market expansion.

The strategic collaborations between healthcare providers, academic institutions, and medical device manufacturers in North America also play a crucial role in accelerating product innovations and expanding treatment accessibility. Moreover, the increasing awareness of stroke symptoms and improved emergency medical services are enabling faster treatment initiation, which is critical in ischemic stroke management.

Therefore, the combination of a growing stroke patient population, an aging demographic, technological advancements, and a supportive regulatory environment positions North America as the leading region in the interventional neuroradiology market during the forecast period (2025 to 2032).

Interventional Neuroradiology Market Key Players:

Some of the key market players operating in the interventional neuroradiology market include Stryker, Boston Scientific Corporation, MicroVention Inc., Cook, Mediterra, Johnson & Johnson, Inc., Merit Medical Systems, Inc., Terumo Corporation, Penumbra, Inc., MicroPort Scientific Corporation, Balt Group, AngioDynamics, Acandis GmBH, Phenox, and InspireMD Inc.

Recent Developmental Activities in the Interventional Neuroradiology Market:

• In October 2023, the Royal Australian and New Zealand College of Radiologists (RANZCR) launched the Standards of Practice for Interventional Radiology and Interventional Neuroradiology during its 72nd Annual Scientific Meeting (ASM) held in Adelaide. These standards aim to enhance patient safety, optimize clinical outcomes, and ensure consistent quality of care in interventional radiology and neuroradiology procedures across the region.
• In June 2022, Stryker announced a partnership with Carmeda to develop an advanced flow diverter featuring active drug coating technology. This collaboration aims to enhance aneurysm treatment by improving device biocompatibility and reducing the risk of thrombosis, ultimately offering better long-term patient outcomes in the management of complex cerebral aneurysms.

Key Takeaways from the Interventional Neuroradiology Market Report Study

• Market size analysis for current interventional neuroradiology market size (2024), and market forecast for 8 years (2025 to 2032)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
• Key companies dominating the interventional neuroradiology market.
• Various opportunities available for the other competitors in the interventional neuroradiology market space.
• What are the top-performing segments in 2024? How these segments will perform in 2032?
• Which are the top-performing regions and countries in the current interventional neuroradiology market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for interventional neuroradiology market growth in the coming future?

Target Audience Who Can be Benefited from this Interventional Neuroradiology Market Report Study

• Interventional neuroradiology product providers
• Research organizations and consulting companies
• Interventional Neuroradiology - related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in the interventional neuroradiology market
• Various end-users who want to know more about the interventional neuroradiology market and the latest technological developments in the interventional neuroradiology market.

Frequently Asked Questions for the Interventional Neuroradiology Market:

1. What is meant by interventional neuroradiology?

• Interventional Neuroradiology is a subspecialty of radiology that focuses on diagnosing and treating disorders of the central nervous system (CNS), including the brain, spine, head, and neck. It combines expertise in neuroanatomy, imaging techniques, and endovascular (within the blood vessels) methods.

2. What is the market for interventional neuroradiology?

• The interventional neuroradiology market was valued at USD 31,198.87 million in 2024, growing at a CAGR of 6.66% during the forecast period from 2025 to 2032 to reach USD 52,081.52 million by 2032.

3. What are the drivers for the global interventional neuroradiology market?

• The interventional neuroradiology market is primarily being boosted by the rising incidence of neurological disorders such as cerebral aneurysms. Additionally, increasing technological advancements in the domain of interventional neuroradiology is another key factor, which is responsible for contributing to the growth of the interventional neuroradiology market during the forecast period from 2025 to 2032.

4. Who are the key players operating in the global interventional neuroradiology market?

• Some of the key market players operating in the interventional neuroradiology market include Stryker, Boston Scientific Corporation, MicroVention Inc., Cook, Mediterra, Johnson & Johnson, Inc., Merit Medical Systems, Inc., Terumo Corporation, Penumbra, Inc., MicroPort Scientific Corporation, Balt Group, AngioDynamics, Acandis GmBH, Phenox, and InspireMD Inc.

5. Which region has the highest share in the global interventional neuroradiology market?

• North America is expected to dominate the overall interventional neuroradiology market during the forecast period, 2025 to 2032. This is due to the presence of a large patient pool suffering from ischemic stroke, and transient ischemic attack (TIA). Additionally, the rising geriatric population, the presence of developed and sophisticated healthcare infrastructure, and a highly viable market in terms of product development, and launches are some of the factors driving the growth of the interventional neuroradiology market in North America.

Table of Contents

1. Interventional Neuroradiology Market Report Introduction

• 1.1. Scope of the Study
• 1.2. Market Segmentation
• 1.3. Market Assumption

2. Interventional Neuroradiology Market Executive Summary

• 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

• 4.1. The United States
• 4.2. Europe
• 4.3. Japan
• 4.4. China

5. Interventional Neuroradiology Market Key Factors Analysis

• 5.1. Interventional Neuroradiology Market Drivers
  • 5.1.1. Rising prevalence of neurological disorders
  • 5.1.2. Growing technical advancements and Innovation
  • 5.1.3. Growing Government Initiatives and favorable Reimbursement policies
• 5.2. Interventional Neuroradiology Market Restraints and Challenges
  • 5.2.1. Complications associated with the use of interventional neuroradiology devices
  • 5.2.2. Stringent regulatory approval of the devices
• 5.3. Interventional Neuroradiology Market Opportunities
  • 5.3.1. Integration of artificial intelligence (AI) and machine learning algorithms in diagnostic imaging for enhancing early detection and treatment planning

6. Interventional Neuroradiology Market Porter's Five Forces Analysis

• 6.1. Bargaining Power of Suppliers
• 6.2. Bargaining Power of Consumers
• 6.3. Threat of New Entrants
• 6.4. Threat of Substitutes
• 6.5. Competitive Rivalry

7. Interventional Neuroradiology Market Assessment

• 7.1. By Device
  • 7.1.1. Micro guidewires
  • 7.1.2. Microcatheters
  • 7.1.3. Flow Diversion Stents
  • 7.1.4. Embolization Coils
  • 7.1.5. Neurovascular Embolization Devices
  • 7.1.6. Others
• 7.2. By Disease
  • 7.2.1. Cerebral Aneurysms
  • 7.2.2. Intracranial Tumors
  • 7.2.3. Acute Ischemic Strokes
  • 7.2.4. Other Diseases
• 7.3. By End-Users
  • 7.3.1. Hospitals
  • 7.3.2. Ambulatory Surgical Centers
  • 7.3.3. Others
• 7.4. By Geography
  • 7.4.1. North America
    • 7.4.1.1. United States Interventional Neuroradiology Market Size in USD million (2022-2032)
    • 7.4.1.2. Canada Interventional Neuroradiology Market Size in USD million (2022-2032)
    • 7.4.1.3. Mexico Interventional Neuroradiology Market Size in USD million (2022-2032)
  • 7.4.2. Europe
    • 7.4.2.1. France Interventional Neuroradiology Market Size in USD million (2022-2032)
    • 7.4.2.2. Germany Interventional Neuroradiology Market Size in USD million (2022-2032)
    • 7.4.2.3. United Kingdom Interventional Neuroradiology Market Size in USD million (2022-2032)
    • 7.4.2.4. Italy Interventional Neuroradiology Market Size in USD million (2022-2032)
    • 7.4.2.5. Spain Interventional Neuroradiology Market Size in USD million (2022-2032)
    • 7.4.2.6. Rest of Europe Interventional Neuroradiology Market Size in USD million (2022-2032)
  • 7.4.3. Asia-Pacific
    • 7.4.3.1. China Interventional Neuroradiology Market Size in USD million (2022-2032)
    • 7.4.3.2. Japan Interventional Neuroradiology Market Size in USD million (2022-2032)
    • 7.4.3.3. India Interventional Neuroradiology Market Size in USD million (2022-2032)
    • 7.4.3.4. Australia Interventional Neuroradiology Market Size in USD million (2022-2032)
    • 7.4.3.5. South Korea Interventional Neuroradiology Market Size in USD million (2022-2032)
    • 7.4.3.6. Rest of Asia-Pacific Interventional Neuroradiology Market Size in USD million (2022-2032)
  • 7.4.4. Rest of the World (RoW)
    • 7.4.4.1. Middle East Interventional Neuroradiology Market Size in USD million (2022-2032)
    • 7.4.4.2. Africa Interventional Neuroradiology Market Size in USD million (2022-2032)
    • 7.4.4.3. South America Interventional Neuroradiology Market Size in USD million (2022-2032)

8. Interventional Neuroradiology Market Company and Product Profiles

• 8.1. Stryker
  • 8.1.1. Company Overview
  • 8.1.2. Company Snapshot
  • 8.1.3. Financial Overview
  • 8.1.4. Product Listing
  • 8.1.5. Entropy
• 8.2. Boston Scientific Corporation
  • 8.2.1. Company Overview
  • 8.2.2. Company Snapshot
  • 8.2.3. Financial Overview
  • 8.2.4. Product Listing
  • 8.2.5. Entropy
• 8.3. MicroVention Inc.
  • 8.3.1. Company Overview
  • 8.3.2. Company Snapshot
  • 8.3.3. Financial Overview
  • 8.3.4. Product Listing
  • 8.3.5. Entropy
• 8.4. Cook
  • 8.4.1. Company Overview
  • 8.4.2. Company Snapshot
  • 8.4.3. Financial Overview
  • 8.4.4. Product Listing
  • 8.4.5. Entropy
• 8.5. Mediterra
  • 8.5.1. Company Overview
  • 8.5.2. Company Snapshot
  • 8.5.3. Financial Overview
  • 8.5.4. Product Listing
  • 8.5.5. Entropy
• 8.6. Johnson & Johnson, Inc.
  • 8.6.1. Company Overview
  • 8.6.2. Company Snapshot
  • 8.6.3. Financial Overview
  • 8.6.4. Product Listing
  • 8.6.5. Entropy
• 8.7. Merit Medical Systems, Inc.
  • 8.7.1. Company Overview
  • 8.7.2. Company Snapshot
  • 8.7.3. Financial Overview
  • 8.7.4. Product Listing
  • 8.7.5. Entropy
• 8.8. Terumo Corporation
  • 8.8.1. Company Overview
  • 8.8.2. Company Snapshot
  • 8.8.3. Financial Overview
  • 8.8.4. Product Listing
  • 8.8.5. Entropy
• 8.9. Penumbra, Inc.
  • 8.9.1. Company Overview
  • 8.9.2. Company Snapshot
  • 8.9.3. Financial Overview
  • 8.9.4. Product Listing
  • 8.9.5. Entropy
• 8.10. MicroPort Scientific Corporation
  • 8.10.1. Company Overview
  • 8.10.2. Company Snapshot
  • 8.10.3. Financial Overview
  • 8.10.4. Product Listing
  • 8.10.5. Entropy
• 8.11. Balt Group
  • 8.11.1. Company Overview
  • 8.11.2. Company Snapshot
  • 8.11.3. Financial Overview
  • 8.11.4. Product Listing
  • 8.11.5. Entropy
• 8.12. AngioDynamics
  • 8.12.1. Company Overview
  • 8.12.2. Company Snapshot
  • 8.12.3. Financial Overview
  • 8.12.4. Product Listing
  • 8.12.5. Entropy
• 8.13. Acandis GmBH
  • 8.13.1. Company Overview
  • 8.13.2. Company Snapshot
  • 8.13.3. Financial Overview
  • 8.13.4. Product Listing
  • 8.13.5. Entropy
• 8.14. Phenox GmbH
  • 8.14.1. Company Overview
  • 8.14.2. Company Snapshot
  • 8.14.3. Financial Overview
  • 8.14.4. Product Listing
  • 8.14.5. Entropy
• 8.15. InspireMD Inc.
  • 8.15.1. Company Overview
  • 8.15.2. Company Snapshot
  • 8.15.3. Financial Overview
  • 8.15.4. Product Listing
  • 8.15.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us